Industry News
High radiotherapy dose improves prospects for children with brain cancer
4/29/2015
Two studies presented at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central...
Breakthrough provides new hope for more effective treatments of HER2+ breast cancer
4/29/2015
Scientists identify key genes and molecules that spur aggressive activityAhmad M. Khalil, PhD, knew the odds were against him -- as in thousands upon thousands to one.
Long lasting anti-hemophilia factor safe in kids
4/29/2015
Recombinant factor VIII fusion protein safely extends time between infusionsChildren with hemophilia A require three to four infusions each week to prevent bleeding episodes, chronic pain and...
Researchers discover new gene strongly linked to breast cancer
4/28/2015
From analyzing populations of Polish and French-Canadian women, researchers find mutations in a gene called RECQL are strongly linked to the development of breast cancer.
Hodgkin lymphoma survivors have higher risk for cardiovascular diseases
4/28/2015
Survivors of Hodgkin lymphoma appear to be at higher risk for cardiovascular diseases and both physicians and patients need to be aware of this increased risk, according to an article published...
UK Trial of radioactive glass particles to tackle cancer
4/28/2015
Cancer treatment with radioactive glass microspheres is to be trialled for the first time in the UK at Oxford's Churchill Hospital.
Health insurance coverage among cancer patients varies greatly by demographics and cancer type
4/28/2015
A new analysis has found that, among patients with cancer, rates of health insurance coverage vary by patient demographics and by cancer type.
New class of cholesterol drug proves safe and effective for patients with dyslipidemia
4/28/2015
Treatment with PCSK9 antibodies reduces mortality and produces profound reductions in LDL-cholesterol and lipoprotein in patients with dyslipidemia.
7 great achievements in child health research celebrated at Pediatric Academic Societies
4/28/2015
Pediatric research discoveries over the past 40 years have led to prevention and treatment strategies that have saved millions of lives worldwide.
Novel therapeutic candidate targets key driver of HCC in genomically defined subset of patients
4/28/2015
Preclinical data demonstrate that BLU-554 is first potent and selective FGFR4 inhibitorFindings were presented at The International Liver CongressTM 2015 on a novel therapeutic candidate for a...